1. Introduction 1.1 Study Deliverables 1.2 General Study Assumptions 2. Research Methodology 2.1 Introduction 2.2 Analysis Methodology 2.3 Study Phases 2.4 Econometric Modeling 3. Executive Summary 4. Market Overview and Trends 4.1 Introduction 4.2 Market Trends 4.3 Porter’s Five Forces Framework 4.3.1 Bargaining Power of Suppliers 4.3.2 Bargaining Power of Consumers 4.3.3 Threat of New Entrants 4.3.4 Threat of Substitute Products and Services 4.3.5 Competitive Rivalry within the Industry 5. Market Dynamics 5.1 Drivers 5.1.1 Introduction of New Types of Vaccines 5.1.2 Initiatives by Various Government Agencies 5.2 Restraints 5.2.1 High Storage Costs for Vaccines 5.3 Opportunities 5.3.1 Technological Advancements 6. Global Poultry Vaccines Market Segmentation, By Diseases 6.1 Bronchitis 6.2 Avian Influenza 6.3 Marek's Disease 6.4 Newcastle Disease 7. Global Poultry Vaccines Market Segmentation, By Technology 7.1 Toxoid Vaccines 7.2 Recombinant Vaccines 7.3 Inactivated Vaccines 7.4 Live Attenuated Vaccines (LAV) 8. Global Poultry Vaccines Market Segmentation, By Geography 8.1 North America 8.1.1 United States 8.1.2 Canada 8.1.3 Rest of North America 8.2 Asia-Pacific 8.2.1 China 8.2.2 Japan 8.2.3 India 8.2.4 Rest of Asia-Pacific 8.3 Europe 8.3.1 United Kingdom 8.3.2 Germany 8.3.3 France 8.3.4 Russia 8.3.5 Rest of Europe 8.4 Rest of the World 8.4.1 Brazil 8.4.2 South Africa 8.4.3 Others 9. Competitive Landscape 9.1 Introduction 9.2 Market Share Analysis 10. Company Profiles 10.1 Boehringer Ingelheim 10.2 Elanco 10.3 Merck & Co. 10.4 Zoetis Inc 10.5 Ceva Animal Health Inc. 10.6 Phibro Animal Health Corporation 10.7 Venkys 10.8 Intervac Pvt Ltd 10.9 Biovet 10.10 Anicon GmbH 10.11 ASP Inc. 11. Future Outlook 12. Disclaimer

Boehringer Ingelheim,Elanco,Merck & Co.,Zoetis Inc,Ceva Animal Health Inc.,Phibro Animal Health Corporation,Venkys,Intervac Pvt Ltd,Biovet,Anicon GmbH,ASP Inc.